trending Market Intelligence /marketintelligence/en/news-insights/trending/syibann99ua9xxdymjcneg2 content esgSubNav
In This List

CSPC Pharmaceutical rotating CEO steps down; replacement named

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


CSPC Pharmaceutical rotating CEO steps down; replacement named

CSPC Pharmaceutical Group Ltd. said Pan Weidong will cease to be rotating CEO, effective May 25.

Weidong will continue to serve as the company's vice chairman and executive director.

CSPC appointed its executive director Wang Zhenguo to serve as vice chairman and rotating CEO.

Zhenguo has served CSPS as an executive director since 2012 and is also a director of certain subsidiaries of the company.

CSPC Pharmaceutical Group is an investment holding company that manufactures and sells pharmaceutical products in the People's Republic of China, other Asian regions, the Americas and Europe.